comparemela.com

Latest Breaking News On - Proc natl acad sci united states - Page 1 : comparemela.com

Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 25, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May 2023 financial key figures: Revenue from contracts with customers of CHF 103.4 million (2022: CHF 7.5 million) Net result of CHF 54.8 million (2022: CHF -71.1 million) Cash flow from operating

Italy
United-states
Highbridge
Somerset
United-kingdom
Spain
Pratteln
Switzerland-general
Switzerland
France
Austria
China

Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China's NMPA

Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China's NMPA
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

China
Morningside
North-lanarkshire
United-kingdom
Pratteln
Switzerland-general
Switzerland
United-states
Swiss
America
Chinese
Eva-kalias

Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)

Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
United-kingdom
Canada
America
Richardj-daly
Lambert-eaton
Life-science-alliance
Catalyst-pharmaceuticals-inc
Licensor-santhera-pharmaceuticals
Properties-in-maintaining-efficacy
Patient-assistance-program
Exchange-commission

Catalyst Pharmaceuticals Announces AGAMREE® Now

Catalyst Pharmaceuticals Announces AGAMREE® Now
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Canada
United-kingdom
United-states
America
Richardj-daly
Lambert-eaton
Catalyst-pharmaceuticals-inc
Life-science-alliance
Patient-assistance-program
Exchange-commission
Licensor-santhera-pharmaceuticals
Properties-in-maintaining-efficacy
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.